Song S - Search Results

1

Potent Activity of the Bromodomain Inhibitor OTX015 in Multiple Myeloma.

Shi J, Song S, Han H, Xu H, Huang M, Qian C, Zhang X, Ouyang L, Hong Y, Zhuang W, Li B. Shi J, et al. Among authors: song s. Mol Pharm. 2018 Sep 4;15(9):4139-4147. doi: 10.1021/acs.molpharmaceut.8b00554. Epub 2018 Aug 9. Mol Pharm. 2018. PMID: 30048594

2

Predicting multi-level drug response with gene expression profile in multiple myeloma using hierarchical ordinal regression.

Zhang X, Li B, Han H, Song S, Xu H, Hong Y, Yi N, Zhuang W. Zhang X, et al. Among authors: song s. BMC Cancer. 2018 May 10;18(1):551. doi: 10.1186/s12885-018-4483-6. BMC Cancer. 2018. PMID: 29747599 Free PMC article.

3

Pathway-structured predictive modeling for multi-level drug response in multiple myeloma.

Zhang X, Li B, Han H, Song S, Xu H, Yi Z, Hong Y, Zhuang W, Yi N. Zhang X, et al. Among authors: song s. Bioinformatics. 2018 Nov 1;34(21):3609-3615. doi: 10.1093/bioinformatics/bty436. Bioinformatics. 2018. PMID: 29850860 Free PMC article.

4

Exosome-mediated transfer of lncRUNX2-AS1 from multiple myeloma cells to MSCs contributes to osteogenesis.

Li B, Xu H, Han H, Song S, Zhang X, Ouyang L, Qian C, Hong Y, Qiu Y, Zhou W, Huang M, Zhuang W. Li B, et al. Among authors: song s. Oncogene. 2018 Oct;37(41):5508-5519. doi: 10.1038/s41388-018-0359-0. Epub 2018 Jun 12. Oncogene. 2018. PMID: 29895968

5

The BET Bromodomain Inhibitor OTX015 Synergizes with Targeted Agents in Multiple Myeloma.

Gu J, Song S, Han H, Xu H, Fan G, Qian C, Qiu Y, Zhou W, Zhuang W, Li B. Gu J, et al. Among authors: song s. Mol Pharm. 2018 Nov 5;15(11):5387-5396. doi: 10.1021/acs.molpharmaceut.8b00880. Epub 2018 Oct 19. Mol Pharm. 2018. PMID: 30339013

6

HOXC10 Regulates Osteogenesis of Mesenchymal Stromal Cells Through Interaction with Its Natural Antisense Transcript lncHOXC-AS3.

Li B, Han H, Song S, Fan G, Xu H, Zhou W, Qiu Y, Qian C, Wang Y, Yuan Z, Gao Y, Zhang Y, Zhuang W. Li B, et al. Among authors: song s. Stem Cells. 2019 Feb;37(2):247-256. doi: 10.1002/stem.2925. Epub 2018 Dec 2. Stem Cells. 2019. PMID: 30353595

7

Exosome-Transmitted PSMA3 and PSMA3-AS1 Promote Proteasome Inhibitor Resistance in Multiple Myeloma.

Xu H, Han H, Song S, Yi N, Qian C, Qiu Y, Zhou W, Hong Y, Zhuang W, Li Z, Li B, Zhuang W. Xu H, et al. Among authors: song s. Clin Cancer Res. 2019 Mar 15;25(6):1923-1935. doi: 10.1158/1078-0432.CCR-18-2363. Epub 2019 Jan 4. Clin Cancer Res. 2019. PMID: 30610101

8

piRNA-30473 contributes to tumorigenesis and poor prognosis by regulating m6A RNA methylation in DLBCL.

Han H, Fan G, Song S, Jiang Y, Qian C, Zhang W, Su Q, Xue X, Zhuang W, Li B. Han H, et al. Among authors: song s. Blood. 2021 Mar 25;137(12):1603-1614. doi: 10.1182/blood.2019003764. Blood. 2021. PMID: 32967010 Free article.

9

Downregulation of ITGA6 confers to the invasion of multiple myeloma and promotes progression to plasma cell leukaemia.

Song S, Zhang J, Su Q, Zhang W, Jiang Y, Fan G, Qian C, Li B, Zhuang W. Song S, et al. Br J Cancer. 2021 May;124(11):1843-1853. doi: 10.1038/s41416-021-01362-5. Epub 2021 Mar 30. Br J Cancer. 2021. PMID: 33785876 Free PMC article.

10

IDH2 contributes to tumorigenesis and poor prognosis by regulating m6A RNA methylation in multiple myeloma.

Song S, Fan G, Li Q, Su Q, Zhang X, Xue X, Wang Z, Qian C, Jin Z, Li B, Zhuang W. Song S, et al. Oncogene. 2021 Sep;40(35):5393-5402. doi: 10.1038/s41388-021-01939-7. Epub 2021 Jul 17. Oncogene. 2021. PMID: 34274946

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15,572 results

Search Page

Filters